6-11005388-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_017770.4(ELOVL2):c.239C>T(p.Ala80Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000011 in 1,461,094 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_017770.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ELOVL2 | NM_017770.4 | c.239C>T | p.Ala80Val | missense_variant | 3/8 | ENST00000354666.4 | NP_060240.3 | |
ELOVL2 | XM_011514716.4 | c.329C>T | p.Ala110Val | missense_variant | 3/8 | XP_011513018.1 | ||
ELOVL2 | XM_011514717.4 | c.242C>T | p.Ala81Val | missense_variant | 3/8 | XP_011513019.1 | ||
ELOVL2 | XM_017010985.2 | c.329C>T | p.Ala110Val | missense_variant | 3/5 | XP_016866474.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ELOVL2 | ENST00000354666.4 | c.239C>T | p.Ala80Val | missense_variant | 3/8 | 1 | NM_017770.4 | ENSP00000346693 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 250358Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135290
GnomAD4 exome AF: 0.0000110 AC: 16AN: 1461094Hom.: 0 Cov.: 30 AF XY: 0.0000124 AC XY: 9AN XY: 726792
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 11, 2024 | The c.239C>T (p.A80V) alteration is located in exon 3 (coding exon 3) of the ELOVL2 gene. This alteration results from a C to T substitution at nucleotide position 239, causing the alanine (A) at amino acid position 80 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at